Dupixent for Children: What Parents Should Ask Their Doctor About Cancer Risk

Dupixent (dupilumab) has been a genuine breakthrough for many families. For children with moderate-to-severe eczema, asthma, and other inflammatory conditions, it has offered meaningful relief when other treatments fell short. The FDA has approved it for children as young as six months, and many pediatric patients have benefited from it….
By: Morris James LLP